{"transactions":[{"id":4627545,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2025-04-28","expiration_date":"2025-09-18","underlying":"Common Stock","underlying_shares":8435},"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627544,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":1000,"value":250000.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2024-02-21","expiration_date":"2025-09-18","underlying":"Common Stock","underlying_shares":11760},"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627543,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."}],"balance_after":57717,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627542,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":8435,"price":16.6,"value":140021.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations."},{"field":"shares","element":"transactionShares","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."}],"balance_after":26341,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627541,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":11760,"price":40.4,"value":475104.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations."},{"field":"shares","element":"transactionShares","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."}],"balance_after":17906,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":687873,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"other","planned":false,"acquired":true,"shares":141462,"price":0.35,"value":49511.7,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On July 10, 2026, the Registrant issued warrants to purchase 374,330 shares of Common Stock (the \"Solicitation Agent Warrants\") to ThinkEquity LLC in connection with a Solicitation Agreement, dated June 25, 2026. The Solicitation Agent Warrants have terms substantially similar to the New Warrants, including with respect to exercise price, expiration and term. ThinkEquity LLC distributed 141,462 Solicitation Agent Warrants to Mr. Stern."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 10, 2026, the Registrant issued warrants to purchase 374,330 shares of Common Stock (the \"Solicitation Agent Warrants\") to ThinkEquity LLC in connection with a Solicitation Agreement, dated June 25, 2026. The Solicitation Agent Warrants have terms substantially similar to the New Warrants, including with respect to exercise price, expiration and term. ThinkEquity LLC distributed 141,462 Solicitation Agent Warrants to Mr. Stern."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 10, 2026, the Registrant issued warrants to purchase 374,330 shares of Common Stock (the \"Solicitation Agent Warrants\") to ThinkEquity LLC in connection with a Solicitation Agreement, dated June 25, 2026. The Solicitation Agent Warrants have terms substantially similar to the New Warrants, including with respect to exercise price, expiration and term. ThinkEquity LLC distributed 141,462 Solicitation Agent Warrants to Mr. Stern."}],"balance_after":141462,"derivative":{"exercise_price":0.35,"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":141462},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687872,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":344710,"price":0.35,"value":120648.5,"ownership":{"direct":false,"nature":"Through A.K.S Family Partners LP"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 10, 2026, Sanitam Parnters LLC (\"Sanitam\") distributed its holdings in the Registrant's preferred stock and warrants to its members. A.K.S. Family Partners LP received a portion of such distribution. As such Sanitam no longer beneficially owns any securities of the Registrant."}],"balance_after":344710,"derivative":{"exercise_price":0.35,"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":344710},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687871,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"other","planned":false,"acquired":false,"shares":344710,"price":0.35,"value":120648.5,"ownership":{"direct":false,"nature":"Through A.K.S Family Partners LP"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 10, 2026, Sanitam Parnters LLC (\"Sanitam\") distributed its holdings in the Registrant's preferred stock and warrants to its members. A.K.S. Family Partners LP received a portion of such distribution. As such Sanitam no longer beneficially owns any securities of the Registrant."}],"balance_after":0,"derivative":{"exercise_price":0.35,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":344710},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687870,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":630335,"price":0.35,"value":220617.25,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."}],"balance_after":630335,"derivative":{"exercise_price":0.35,"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":630335},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687869,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"other","planned":false,"acquired":false,"shares":630335,"price":0.35,"value":220617.25,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."}],"balance_after":0,"derivative":{"exercise_price":0.35,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":630335},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687868,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2025-10-31","kind":"other","planned":false,"acquired":false,"shares":92100,"price":0.6446,"value":59367.66,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."}],"balance_after":630335,"derivative":{"exercise_price":0.6446,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":92100},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687867,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2025-10-16","kind":"other","planned":false,"acquired":true,"shares":265,"price":0.586,"value":155.29,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."}],"balance_after":265,"derivative":{"exercise_price":0.586,"exercise_date":"2025-04-04","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":452218},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687866,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:04:03.000Z","date":"2025-10-16","kind":"other","planned":false,"acquired":true,"shares":800000,"price":0.6446,"value":515680.0,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."}],"balance_after":800000,"derivative":{"exercise_price":0.6446,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687865,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"other","planned":false,"acquired":true,"shares":630335,"price":0.35,"value":220617.25,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."}],"balance_after":743785,"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687864,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-13T20:04:03.000Z","date":"2026-07-10","kind":"other","planned":false,"acquired":true,"shares":344710,"price":0.35,"value":120648.5,"ownership":{"direct":false,"nature":"Through A.K.S Family Partners LP"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."}],"balance_after":416900,"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":687863,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-13T20:04:03.000Z","date":"2025-10-31","kind":"other","planned":false,"acquired":true,"shares":92100,"price":0.6446,"value":59367.66,"ownership":{"direct":false,"nature":"Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 16, 2025, SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern received 800,000 Warrants to purchase Common Stock and 265 shares of Series C Convertible Preferred Stock in connection with a settlement agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 10, 2026, the Registrant entered into inducement offer letter agreements with certain Reporting Persons, pursuant to which such Reporting Persons agreed to exercise for cash all of their outstanding warrants at the current exercise price of $0.35 per share in consideration for the Registrant's agreement to issue, in a private placement, new unregistered common stock purchase warrants (the \"New Warrants\"). The Registrant is required to obtain stockholder approval (\"Inducement Stockholder Approval\") for the issuance of the shares of common stock underlying the New Warrants. The New Warrants will be exercisable beginning on the date Inducement Stockholder Approval is received at an exercise price of $0.35 per share and will expire on the five-year anniversary of the date Inducement Stockholder Approval is received."}],"balance_after":113450,"source":{"system":"sec-edgar","filing":"0000921895-26-002109","document":"form413617016ste_08132026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000092189526002109/form413617016ste_08132026.xml","form_type":"4"}},{"id":927859,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T00:47:16.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on March 20, 2025, the Issuer conducted a reverse stock split of its common stock at a ratio of 1-for-12 (the \"Reverse Split\"). All share numbers reported herein give effect to the Reverse Split."}],"balance_after":19899,"source":{"system":"sec-edgar","filing":"0001193125-26-029875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312526029875/ownership.xml","form_type":"4"}},{"id":1040256,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T22:03:10.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":29717,"source":{"system":"sec-edgar","filing":"0001104659-25-090097","document":"tm2526001-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465925090097/tm2526001-2_4seq1.xml","form_type":"4"}},{"id":1305050,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2025-01-10T21:04:16.000Z","date":"2025-01-07","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":false,"nature":"AKS Family Partners L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."}],"balance_after":0,"derivative":{"exercise_price":0.83,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-25-002530","document":"tm252765-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465925002530/tm252765-1_4seq1.xml","form_type":"4"}},{"id":1436904,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T20:01:03.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the next annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control."}],"balance_after":58821,"source":{"system":"sec-edgar","filing":"0000950170-24-094723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017024094723/ownership.xml","form_type":"4"}},{"id":1586486,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T21:15:14.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period."}],"balance_after":194341,"source":{"system":"sec-edgar","filing":"0001104659-24-032397","document":"tm248350-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465924032397/tm248350-1_4seq1.xml","form_type":"4"}},{"id":1606733,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series-C Preferred Stock","published_at":"2024-03-01T21:01:15.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":250,"price":1000,"value":250000.0,"ownership":{"direct":false,"nature":"AKS Family Partnership, L.P"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to beneficial ownership limitations provided for in the offering documents relating to the sale of the Series-C Preferred Stock, each share of Series-C Preferred Stock shall automatically convert into shares of the registrant's common stock at the conversion price of $2.02 upon the earlier of (i) the 15-month anniversary of the effective date of the certificate of designation, or (ii) the consent to conversion by holders of at least 50.1% of the outstanding shares of Series-C Preferred."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to beneficial ownership limitations provided for in the offering documents relating to the sale of the Series-C Preferred Stock, each share of Series-C Preferred Stock shall automatically convert into shares of the registrant's common stock at the conversion price of $2.02 upon the earlier of (i) the 15-month anniversary of the effective date of the certificate of designation, or (ii) the consent to conversion by holders of at least 50.1% of the outstanding shares of Series-C Preferred."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Series C Preferred Stock initially converts into shares of common stock at a conversion price of $2.02. In addition, the holders of Series c Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to seven and a half percent (7.5%) of the number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to fifteen percent (15%) of the number of shares of common stock issuable upon conversion of the Series C Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":250,"derivative":{"exercise_price":2.02,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-24-029952","document":"tm247605-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465924029952/tm247605-1_4seq1.xml","form_type":"4"}},{"id":1736644,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T23:43:26.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of November 17, 2024 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."}],"balance_after":39214,"source":{"system":"sec-edgar","filing":"0000950170-23-064956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023064956/ownership.xml","form_type":"4"}},{"id":2117895,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T02:12:50.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of November 9, 2023 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."}],"balance_after":19607,"source":{"system":"sec-edgar","filing":"0000899243-22-035798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924322035798/doc4.xml","form_type":"4"}},{"id":2261648,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:00:41.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 33.333% shall vest after 12 months from the grant date, and the remaining shares shall vest in 2 equal instalments every 2 years thereafter."}],"balance_after":124341,"source":{"system":"sec-edgar","filing":"0001104659-22-063443","document":"tm2216123-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465922063443/tm2216123-1_4seq1.xml","form_type":"4"}},{"id":2544476,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-12T22:00:29.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders."}],"balance_after":17500,"derivative":{"exercise_price":6.7,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-21-039908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321039908/doc4.xml","form_type":"4"}},{"id":2766267,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-31T20:11:56.000Z","date":"2021-01-19","kind":"purchase","acquired":true,"shares":43850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The shares vest over three years as follows: one third of the shares vest on each annual anniversary date of the date of grant; provided, however that the shares shall vest on a pro rata basis on the date the Reporting Person's continuous service to the Issuer ceases. The shares shall immediately vest in the event of a change of control that occurs prior to, or within, 60 days of the termination of the Reporting Person's employment or retention with the Issuer."}],"balance_after":68103,"source":{"system":"sec-edgar","filing":"0001104659-21-044751","document":"tm2111379d3_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465921044751/tm2111379d3_4a.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2812542,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T21:31:54.000Z","date":"2021-03-01","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of March 2021."}],"balance_after":69341,"source":{"system":"sec-edgar","filing":"0001104659-21-031483","document":"tm218474-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465921031483/tm218474-1_4seq1.xml","form_type":"4"}},{"id":2876528,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T21:29:38.000Z","date":"2021-02-03","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of February 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of February 2021."}],"balance_after":68772,"source":{"system":"sec-edgar","filing":"0001104659-21-012964","document":"tm215402d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465921012964/tm215402d1_4seq1.xml","form_type":"4"}},{"id":2900578,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-01-21T21:07:35.000Z","date":"2021-01-19","kind":"purchase","acquired":true,"shares":43850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":68103,"source":{"system":"sec-edgar","filing":"0001104659-21-006289","document":"tm213677-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465921006289/tm213677-4_4seq1.xml","form_type":"4"}},{"id":2915230,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:05:57.000Z","date":"2021-01-04","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of January 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of January 2021."}],"balance_after":24253,"source":{"system":"sec-edgar","filing":"0001104659-21-001489","document":"tm211458d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465921001489/tm211458d1_4.xml","form_type":"4"}},{"id":2956464,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T21:05:24.000Z","date":"2020-12-02","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of December 2020."}],"balance_after":23634,"source":{"system":"sec-edgar","filing":"0001104659-20-132410","document":"tm2037549d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920132410/tm2037549d1_4.xml","form_type":"4"}},{"id":2992535,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:05:45.000Z","date":"2020-11-02","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of November 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of November 2020."}],"balance_after":23015,"source":{"system":"sec-edgar","filing":"0001104659-20-121339","document":"tm2034917d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920121339/tm2034917d1_4.xml","form_type":"4"}},{"id":2998582,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-10-28T20:05:25.000Z","date":"2020-10-27","kind":"grant","acquired":true,"shares":502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were issued in the reporting person's name as a portion of the consideration provided to the placement agent (for whom the reporting person serves as Head of Private Equity Banking)."}],"balance_after":502,"derivative":{"exercise_price":7.94,"exercise_date":"2020-07-31","expiration_date":"2025-07-31","underlying":"Common Stock","underlying_shares":502},"source":{"system":"sec-edgar","filing":"0001104659-20-118931","document":"tm2034485d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920118931/tm2034485d1_4.xml","form_type":"4"}},{"id":2998581,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-10-28T20:05:25.000Z","date":"2020-10-27","kind":"grant","acquired":true,"shares":112365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were issued in the reporting person's name as a portion of the consideration provided to the placement agent (for whom the reporting person serves as Head of Private Equity Banking)."}],"balance_after":112365,"derivative":{"exercise_price":7.47,"exercise_date":"2020-07-31","expiration_date":"2025-07-31","underlying":"Common Stock","underlying_shares":112365},"source":{"system":"sec-edgar","filing":"0001104659-20-118931","document":"tm2034485d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920118931/tm2034485d1_4.xml","form_type":"4"}},{"id":3012967,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:05:42.000Z","date":"2020-10-02","kind":"purchase","acquired":true,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of October 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of October 2020."}],"balance_after":22396,"source":{"system":"sec-edgar","filing":"0001104659-20-112181","document":"tm2032363d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920112181/tm2032363d1_4.xml","form_type":"4"}},{"id":3028416,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:27:39.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable over 12 equal quarterly installments measured from September 15, 2020."}],"balance_after":35000,"derivative":{"exercise_price":7.64,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-051053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919120051053/doc4.xml","form_type":"4"}},{"id":3037429,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-04T20:05:52.000Z","date":"2020-09-03","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of September 2020."}],"balance_after":21777,"source":{"system":"sec-edgar","filing":"0001104659-20-102624","document":"tm2030202d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920102624/tm2030202d1_4.xml","form_type":"4"}},{"id":3048592,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T20:06:14.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of August 2020."}],"balance_after":21138,"source":{"system":"sec-edgar","filing":"0001104659-20-097973","document":"tm2029295d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920097973/tm2029295d1_4.xml","form_type":"4"}},{"id":3048591,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-08-24T14:00:07.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":20000,"price":0.83,"value":16600.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3301983,"source":{"system":"sec-edgar","filing":"0001493152-20-016580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315220016580/ownership.xml","form_type":"4"}},{"id":3077657,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T20:11:49.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2020."}],"balance_after":20499,"source":{"system":"sec-edgar","filing":"0001104659-20-085630","document":"tm2025176d9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920085630/tm2025176d9_4.xml","form_type":"4"}},{"id":3084891,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":1244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."}],"balance_after":1244,"derivative":{"exercise_price":4.98,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":1244},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084890,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":2633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."}],"balance_after":2633,"derivative":{"exercise_price":4.28,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":2633},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084889,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":1593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person."}],"balance_after":1593,"derivative":{"exercise_price":4.05,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":1593},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084888,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":807,"derivative":{"exercise_price":5.9,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084887,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"disposition_to_issuer","acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":0,"derivative":{"exercise_price":5.9,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084886,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":36900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The two reported transactions involved an amendment of an outstanding  pursuant to a transfer of a portion of the Warrant with Michael Siek common stock warrant, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The two reported transactions involved an amendment of an outstanding  pursuant to a transfer of a portion of the Warrant with Michael Siek common stock warrant, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":36900,"derivative":{"exercise_price":4.98,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":36900},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084885,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"disposition_to_issuer","acquired":false,"shares":10086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The two reported transactions involved an amendment of an outstanding  pursuant to a transfer of a portion of the Warrant with Michael Siek common stock warrant, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The two reported transactions involved an amendment of an outstanding  pursuant to a transfer of a portion of the Warrant with Michael Siek common stock warrant, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":0,"derivative":{"exercise_price":4.98,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":10086},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084884,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":22108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":22108,"derivative":{"exercise_price":4.28,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":22108},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084883,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"disposition_to_issuer","acquired":false,"shares":25676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":0,"derivative":{"exercise_price":4.28,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":25676},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084882,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":231383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of such warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of such warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":231383,"derivative":{"exercise_price":4.05,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":231383},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3084881,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-07-10T20:05:25.000Z","date":"2020-07-08","kind":"disposition_to_issuer","acquired":false,"shares":253911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of such warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of such warrant with Michael Siek, resulting in the deemed cancellation of the \"old\" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019."}],"balance_after":0,"derivative":{"exercise_price":4.05,"exercise_date":"2019-12-19","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":253911},"source":{"system":"sec-edgar","filing":"0001104659-20-082723","document":"tm2024537d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920082723/tm2024537d1_4.xml","form_type":"4"}},{"id":3088619,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-06T20:10:19.000Z","date":"2020-07-03","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of July 2020."}],"balance_after":19049,"source":{"system":"sec-edgar","filing":"0001104659-20-081207","document":"tm2024118-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920081207/tm2024118-2_4.xml","form_type":"4"}},{"id":3100759,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-25T01:00:12.000Z","date":"2020-06-23","kind":"other","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3281983,"source":{"system":"sec-edgar","filing":"0001493152-20-011758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315220011758/ownership.xml","form_type":"4"}},{"id":3116129,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:41.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":500,"price":5.91,"value":2955.0,"ownership":{"direct":false,"nature":"AKS Family Partners"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.86 to $5.94, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":15500,"source":{"system":"sec-edgar","filing":"0001104659-20-071370","document":"tm2022156d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920071370/tm2022156d2_4.xml","form_type":"4"}},{"id":3116128,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:41.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":500,"price":5.88,"value":2940.0,"ownership":{"direct":false,"nature":"AKS Family Foundation, Inc."},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-20-071370","document":"tm2022156d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920071370/tm2022156d2_4.xml","form_type":"4"}},{"id":3116127,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:41.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":1500,"price":5.89,"value":8835.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.70 to $5.96, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":18410,"source":{"system":"sec-edgar","filing":"0001104659-20-071370","document":"tm2022156d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920071370/tm2022156d2_4.xml","form_type":"4"}},{"id":3120171,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T20:01:28.000Z","date":"2020-06-03","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of June 2020."}],"balance_after":16910,"source":{"system":"sec-edgar","filing":"0001104659-20-070282","document":"tm2021817d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920070282/tm2021817d1_4.xml","form_type":"4"}},{"id":3156223,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:06:50.000Z","date":"2020-05-07","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waivinglieu of consulting fees owed for the month of May 2020."}],"balance_after":16271,"source":{"system":"sec-edgar","filing":"0001104659-20-058794","document":"tm2018953d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920058794/tm2018953d1_4.xml","form_type":"4"}},{"id":3171686,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-22T20:29:24.000Z","date":"2020-04-20","kind":"purchase","acquired":true,"shares":639,"price":6.66,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving consulting fees owed for the month of April 2020."}],"balance_after":14993,"source":{"system":"sec-edgar","filing":"0001104659-20-049736","document":"tm2016474d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920049736/tm2016474d1_4.xml","form_type":"4"}},{"id":3179631,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-04-08T20:38:42.000Z","date":"2020-04-03","kind":"exercise","acquired":false,"shares":952676,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2015-04-10","expiration_date":"2020-04-09","underlying":"Common Stock","underlying_shares":952676},"source":{"system":"sec-edgar","filing":"0001493152-20-006066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315220006066/ownership.xml","form_type":"4"}},{"id":3179630,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-04-08T20:38:42.000Z","date":"2020-04-03","kind":"exercise","acquired":true,"shares":278407,"price":0.5,"value":139203.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 3, 2020, the reporting person exercised a warrant to purchase 952,676 shares of Matinas BioPharma Holdings, Inc. common stock for $0.50 a share. The reporting person paid the exercise price on a cashless basis, resulting in Matinas BioPharma Holdings, Inc.'s withholding of 674,269 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 278,407 shares. The value of the shares cancelled was $0.7065 per share, which represents the average closing price of the shares for the 20 trading days immediately preceding the date of exercise."}],"balance_after":1337399,"source":{"system":"sec-edgar","filing":"0001493152-20-006066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315220006066/ownership.xml","form_type":"4"}},{"id":3180556,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T20:05:52.000Z","date":"2020-04-03","kind":"purchase","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the month of March 2020."}],"balance_after":14993,"source":{"system":"sec-edgar","filing":"0001104659-20-044151","document":"tm2015091d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920044151/tm2015091d2_4.xml","form_type":"4"}},{"id":3197824,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-23T11:01:19.000Z","date":"2020-03-20","kind":"purchase","acquired":true,"shares":14500,"price":3.8,"value":55100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.44 to $4.30, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001104659-20-037061","document":"tm2013458d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465920037061/tm2013458d1_4.xml","form_type":"4"}},{"id":3202279,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-03-18T14:51:42.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":10000,"price":0.65,"value":6500.0,"ownership":{"direct":false,"nature":"Held by SternAegis Ventures, LLC 401(k) Profit Sharing Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.64 to $0.65, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-20-004196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315220004196/ownership.xml","form_type":"4"}},{"id":3380054,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-11-05T21:05:13.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":107416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":107416,"derivative":{"exercise_price":0.912,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":107416},"source":{"system":"sec-edgar","filing":"0001493152-19-016457","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219016457/ownership.xml","form_type":"4"}},{"id":3400840,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-10-02T22:08:22.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Converts automatically into Common Stock upon the earlier of (i) notice by the Issuer to the holders that the Issuer elected to convert all outstanding shares of Class A Preferred, (ii) July 29, 2019, (iii) the approval of the Issuer's MAT2203 product candidate by the U.S. Food and Drug Administration or the European Medicines Agency (the \"Regulatory Approval\") or (iv) the Regulatory Approval of the Issuer's MAT2501 product candidate."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-07-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3400839,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-10-02T22:08:22.000Z","date":"2016-07-29","kind":"purchase","acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Converts automatically into Common Stock upon the earlier of (i) notice by the Issuer to the holders that the Issuer elected to convert all outstanding shares of Class A Preferred, (ii) July 29, 2019, (iii) the approval of the Issuer's MAT2203 product candidate by the U.S. Food and Drug Administration or the European Medicines Agency (the \"Regulatory Approval\") or (iv) the Regulatory Approval of the Issuer's MAT2501 product candidate."}],"balance_after":20000,"derivative":{"exercise_price":0,"exercise_date":"2016-07-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3400838,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:08:22.000Z","date":"2019-06-21","kind":"other","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3256483,"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3400837,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:08:22.000Z","date":"2019-03-19","kind":"other","acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1058992,"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3400836,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:08:22.000Z","date":"2019-07-26","kind":"other","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series A Preferred Stock of 2.4 shares of Common Stock for each share of Series A Preferred Stock."}],"balance_after":1052392,"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3400835,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:08:22.000Z","date":"2019-07-26","kind":"exercise","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":993992,"source":{"system":"sec-edgar","filing":"0001493152-19-014911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219014911/ownership.xml","form_type":"4"}},{"id":3432003,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-08-21T13:45:16.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":10400,"price":0.6988,"value":7267.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.69 to $0.70, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":804392,"source":{"system":"sec-edgar","filing":"0000905718-19-000718","document":"matinasbio_fm4aug192019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571819000718/matinasbio_fm4aug192019.xml","form_type":"4"}},{"id":3486007,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-06-18T14:00:23.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":15000,"price":0.8,"value":12000.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3239483,"source":{"system":"sec-edgar","filing":"0001493152-19-009354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219009354/ownership.xml","form_type":"4"}},{"id":3491189,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-06-13T16:49:56.000Z","date":"2019-06-12","kind":"purchase","acquired":true,"shares":20000,"price":0.7999,"value":15998.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.7966 to $0.8021, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3224483,"source":{"system":"sec-edgar","filing":"0001493152-19-009097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219009097/ownership.xml","form_type":"4"}},{"id":3493962,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-06-11T21:00:26.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":15000,"price":0.82,"value":12300.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.79 to $0.83, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3204483,"source":{"system":"sec-edgar","filing":"0001493152-19-009014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219009014/ownership.xml","form_type":"4"}},{"id":3495593,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-06-10T21:00:22.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":20000,"price":0.89,"value":17800.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3189483,"source":{"system":"sec-edgar","filing":"0001493152-19-008941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219008941/ownership.xml","form_type":"4"}},{"id":3504496,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-06-03T21:00:11.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":80000,"price":0.94,"value":75200.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.92 to $0.95, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3169483,"source":{"system":"sec-edgar","filing":"0001493152-19-008568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219008568/ownership.xml","form_type":"4"}},{"id":3518345,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-05-20T22:40:33.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":150000,"price":0.95,"value":142500.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.92 to $0.95, inclusive. Upon request of the SEC staff, the reporting person will provide full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3089483,"source":{"system":"sec-edgar","filing":"0001493152-19-007949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000149315219007949/ownership.xml","form_type":"4"}},{"id":3774021,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T13:17:17.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128299,"derivative":{"exercise_price":0.74,"exercise_date":"2018-11-01","expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571818000908/ownership.xml","form_type":"4"}},{"id":3774020,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T13:17:17.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":128299,"derivative":{"exercise_price":0.74,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571818000908/ownership.xml","form_type":"4"}},{"id":3884907,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-22T20:36:59.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":85,"price":1000,"value":85000.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 21, 2018, AKS Family Partners LP purchased 85 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 21, 2018, AKS Family Partners LP purchased 85 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":85,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0000905718-18-000588","document":"stern_matinas-fm4jun212018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571818000588/stern_matinas-fm4jun212018.xml","form_type":"4"}},{"id":4118921,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-12-29T21:39:55.000Z","date":"2017-12-27","kind":"gift","acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":2939483,"source":{"system":"sec-edgar","filing":"0000905718-17-001060","document":"stern_fm4dec272017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571817001060/stern_fm4dec272017.xml","form_type":"4"}},{"id":4118920,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-12-29T21:39:55.000Z","date":"2017-12-27","kind":"gift","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by AKS Family Foundation, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":1750000,"source":{"system":"sec-edgar","filing":"0000905718-17-001060","document":"stern_fm4dec272017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571817001060/stern_fm4dec272017.xml","form_type":"4"}},{"id":4212689,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-09-11T13:03:27.000Z","date":"2017-09-08","kind":"purchase","acquired":true,"shares":50000,"price":1.38,"value":69000.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.39, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3689483,"source":{"system":"sec-edgar","filing":"0000905718-17-000831","document":"stern_fm4sept72017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571817000831/stern_fm4sept72017.xml","form_type":"4"}},{"id":4212688,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-09-11T13:03:27.000Z","date":"2017-09-07","kind":"purchase","acquired":true,"shares":50000,"price":1.38,"value":69000.0,"ownership":{"direct":false,"nature":"Held by AKS Family Partners LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":3639483,"source":{"system":"sec-edgar","filing":"0000905718-17-000831","document":"stern_fm4sept72017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000090571817000831/stern_fm4sept72017.xml","form_type":"4"}}]}